Clinical trial / 2006
A lifestyle intervention reducing dietary fat intake may improve relapse-free survival in women with early-stage breast cancer.
A randomized prospective trial assigned 2,437 women with resected early-stage breast cancer to a dietary fat-reduction intervention (n = 975) or control (n = 1,462). After a median follow-up of 60 months, fat intake was lower in the intervention group (33.3 vs. 51.3 g/day at 12 months; P < .001), alongside a 6-pound lower mean body weight (P = .005). Relapse events occurred in 9.8% of the intervention group and 12.4% of controls, corresponding to a hazard ratio of 0.76 (95% CI = 0.60 to 0.98; P = .077 for stratified log rank, P = .034 for adjusted Cox model).
- Study type
- Randomized controlled trial
- Who was studied
- 2,437 women with resected early-stage breast cancer
- What was measured
- Relapse-free survival
THE PAPER
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM. J Natl Cancer Inst, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.